Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 or 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05806190
What this trial is testing

Hypoglycaemia (Low Blood Sugar) in Adults With Diabetes and Adrenal Failure

Who this might be right for
Diabetes Mellitus, Type 1Adrenal InsufficiencyDiabetes Mellitus Type 2 - Insulin-Treated
Imperial College Healthcare NHS Trust 32
Testing effectiveness (Phase 2)Study completedNCT04663282
What this trial is testing

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 179
Not applicableStudy completedNCT01542424
What this trial is testing

An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,889
Testing effectiveness (Phase 2)UnknownNCT05448820
What this trial is testing

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Advanced SarcomaMetastatic SarcomaSoft Tissue Sarcoma
Tracon Pharmaceuticals Inc. 15
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Study completedNCT02806973
What this trial is testing

Single or Repeated Doses of Glucagon in Participants With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 32
Not applicableEnded earlyNCT02080741
What this trial is testing

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Who this might be right for
Patients With Type 1 or Type 2 DiabetesPatients With a Type A or B Behaviour Profile
Centre Hospitalier Universitaire Dijon 57
Not applicableEnded earlyNCT03017287
What this trial is testing

Safety and Efficacy of the GlucoMe APP in Patients With Uncontrolled Diabetes Treated With MDI

Who this might be right for
Diabetes Mellitus, Type 1 or 2
GlucoMe 40
Post-approval studies (Phase 4)Study completedNCT00420095
What this trial is testing

Patients With Diabetes Mellitus (IOPA)

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Eli Lilly and Company 117
Testing effectiveness (Phase 2)Ended earlyNCT01029795
What this trial is testing

LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 38
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableStudy completedNCT00659295
What this trial is testing

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 51,170
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Not applicableStudy completedNCT00286572
What this trial is testing

Long-term Mortality in Diabetics Undergoing Major Surgery

Who this might be right for
Diabetes MellitusCoronary Heart DiseaseMajor Non-cardiac Surgery
University Hospital, Basel, Switzerland 380
Not applicableLooking for participantsNCT07579702
What this trial is testing

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Who this might be right for
Type 2 Diabetes MellitusType 1 Diabetes Mellitus
Insulet Corporation 200
Not applicableStudy completedNCT02168348
What this trial is testing

Impact of Malnutrition on the Healing of Foot Lesions in Diabetic Patients

Who this might be right for
Patients With Type 1 or 2 DiabetesLesion Situated on a Toe or on the Plantar or Dorsal Side of the Foot
Centre Hospitalier Universitaire Dijon 75
Testing effectiveness (Phase 2)Study completedNCT00476931
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 91
Not applicableNot Yet RecruitingNCT07822555
What this trial is testing

A Novel Miniature Equine-Assisted Diabetes Education Program for Youth: Evaluating the Diabetes Equine Empowerment Program (DEEP).

Who this might be right for
Diabetes (Insulin-requiring, Type 1 or Type 2)Pediatric DiabetesDiabetes (DM)
Nemours Children's Clinic 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06972459
What this trial is testing

Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Eli Lilly and Company 800
Not applicableStudy completedNCT03010956
What this trial is testing

Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.

Who this might be right for
Diabetes Mellitus
University of Athens 100
Next Page